Pharmaniaga Berhad Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PHARMA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders60,325,3344.19%
Institutions156,074,68610.8%
General Public445,417,94530.9%
Private Companies779,411,56154.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 68.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
47.1%
Boustead Holdings Berhad
679,152,075RM 142.6m0%no data
7.83%
Lembaga Tabung Angkatan Tentera
112,916,620RM 23.7m0%1.31%
4.19%
East Navigators Capital Ltd
60,364,286RM 12.7m-29.6%no data
2.15%
Kenanga Investors Bhd.
31,020,866RM 6.5m0%0.14%
1.12%
Minat Megah Sdn. Bhd.
16,100,000RM 3.4m0%no data
0.99%
Boon Wy Tan
14,285,714RM 3.0m0%no data
0.68%
Dasar Technologies Sdn Bhd
9,750,000RM 2.0m0%no data
0.59%
Che bin Wok Kamaruddin
8,475,000RM 1.8m0%no data
0.55%
Standard Chartered Bank Malaysia Berhad, Asset Management Arm
7,906,200RM 1.7m0%100.0%
0.48%
Muthukumar Ayarpadde
6,849,000RM 1.4m0%no data
0.28%
Siew Yoon Yong
4,056,820RM 851.9k0%no data
0.28%
Chi Lik Teng
4,000,000RM 840.0k0%no data
0.28%
Chee Kheng Yap
4,000,000RM 840.0k0%no data
0.27%
Public Gold Marketing Sdn. Bhd
3,900,000RM 819.0k0%no data
0.24%
Lembaga Tabung Amanah Melaka
3,500,000RM 735.0k0%no data
0.24%
Seng Kian Poh
3,499,000RM 734.8k0%no data
0.21%
Parmjit A. Meva Singh
3,020,200RM 634.3k0%no data
0.21%
Celeste Resources Sdn Bhd
3,001,400RM 630.3k0%no data
0.21%
Yayasan Warisan Perajurit, Endowment Arm
2,981,000RM 626.0k0%100.0%
0.19%
Mohd Bin Mohd Yusuf
2,794,300RM 586.8k0%no data
0.17%
Mun Yue Au Yong
2,500,000RM 525.0k0%no data
0.15%
Salma Binti Seman
2,100,000RM 441.0k0%no data
0.14%
Celeste Assets Sdn Bhd
2,000,000RM 420.0k0%no data
0.11%
Mazlan Bin Mohd Noor
1,645,300RM 345.5k0%no data
0.11%
Agromate Holdings Sdn Bhd
1,643,800RM 345.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 22:19
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharmaniaga Berhad is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsien Jin LamCGS International
Yee LowHong Leong Investment Bank Berhad
Min-Tze ChuaKenanga Research